The final endpoints of the model (pay-offs) were expressed in terms of antiemetic treatment cost, inclusive of antiemetic drug cost (palonosetron or ondansetron) and costs incurred for emesis ...

A new study analyzes the disease burden and the risk factors for severity among people who suffer from a condition called ...

Patients treated with tyrosine kinase inhibitors received olanzapine to address adverse effects including nausea/vomiting, ...

However, none of the PDE4 inhibitors tested so far has reached the market, mainly owing to tolerability issues such as emesis. A study in Nature Biotechnology that sheds light on the structural ...